These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7606108)

  • 1. Treatment of advanced hepatocellular carcinoma.
    Tanikawa K; Tanaka M
    Intern Med; 1995 Apr; 34(4):300-2. PubMed ID: 7606108
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy for advanced hepatocellular carcinoma: systemic chemotherapy or hepatic arterial infusion chemotherapy?
    Yamashita T
    J Gastroenterol; 2004; 39(4):404-6. PubMed ID: 15168258
    [No Abstract]   [Full Text] [Related]  

  • 3. [Local, non-surgical treatment of hepatocellular carcinoma].
    Roche A
    Ann Chir; 1998; 52(1):75-8. PubMed ID: 9752414
    [No Abstract]   [Full Text] [Related]  

  • 4. Regional cancer chemotherapy for advanced stage hepatocellular carcinoma.
    Carr BI; Iwatsuki S; Starzl TE; Selby R; Madariaga J
    J Surg Oncol Suppl; 1993; 3():100-3. PubMed ID: 8389153
    [No Abstract]   [Full Text] [Related]  

  • 5. Regorafenib: a newly approved drug for advanced hepatocellular carcinoma.
    Kyrochristos ID; Ziogas DE; Roukos DH
    Future Oncol; 2017 Aug; 13(19):1665-1668. PubMed ID: 28613123
    [No Abstract]   [Full Text] [Related]  

  • 6. Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond.
    Gadaleta-Caldarola G; Divella R; Mazzocca A; Infusino S; Ferraro E; Filippelli G; Daniele A; Sabbà C; Abbate I; Brandi M
    Future Oncol; 2015; 11(16):2263-6. PubMed ID: 26260805
    [No Abstract]   [Full Text] [Related]  

  • 7. Apatinib for hepatocellular carcinoma.
    Ni Y; Ye X
    J Cancer Res Ther; 2019; 15(4):741-742. PubMed ID: 31436225
    [No Abstract]   [Full Text] [Related]  

  • 8. [Basic and clinical study of interferon a in hepatocellular carcinoma].
    Sun HC; Wang L; Wu WZ
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1606-8. PubMed ID: 19094750
    [No Abstract]   [Full Text] [Related]  

  • 9. Sorafenib in hepatocellular carcinoma.
    Josephs DH; Ross PJ
    Br J Hosp Med (Lond); 2010 Aug; 71(8):451-6. PubMed ID: 20852487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closing remarks.
    Kudo M
    Clin Drug Investig; 2012 Aug; 32 Suppl 2():52. PubMed ID: 22873627
    [No Abstract]   [Full Text] [Related]  

  • 11. Rupture of a Small Hepatocellular Carcinoma in a Stable Disease State in a Patient Receiving Sorafenib Treatment.
    Tsuboi R; Asano T; Matsuura K; Asabe S; Mashima H
    Chin Med J (Engl); 2018 Apr; 131(8):999-1000. PubMed ID: 29664064
    [No Abstract]   [Full Text] [Related]  

  • 12. Regorafenib as treatment for patients with advanced hepatocellular cancer.
    Thillai K; Srikandarajah K; Ross P
    Future Oncol; 2017 Oct; 13(25):2223-2232. PubMed ID: 28766967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinative treatment of transarterial chemoembolization, celecoxib and lanreotide in unresectable hepatocellular carcinoma.
    Tong H; Li X; Wei B; Tang C
    Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):e65-6. PubMed ID: 25746137
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of an advanced hepatocellular carcinoma with the long-acting somatostatin analog lanreotide.
    Raderer M; Hejna MH; Kurtaran A; Kornek GV; Valencak JB; Oberhuber G; Vorbeck F; Virgolini I; Scheithauer W
    Am J Gastroenterol; 1999 Jan; 94(1):278-9. PubMed ID: 9934776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the optimal treatment of metastatic hepatocellular carcinoma after complete resection; case presentation of ovarian metastasis.
    Cil I; Zirtiloglu A; Velibeyoglu MF; Tural D
    J BUON; 2017; 22(2):557-558. PubMed ID: 28534387
    [No Abstract]   [Full Text] [Related]  

  • 16. Dramatic reduction in tumour size in hepatocellular carcinoma patients on thalidomide therapy.
    Demeria D; Birchall I; Bain VG
    Can J Gastroenterol; 2007 Aug; 21(8):517-8. PubMed ID: 17703252
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatocellular carcinoma associated with polyarteritis nodosa with symptoms appearing after intra-arterial chemotherapy.
    Minakuchi K; Fujimoto K; Takada K; Takashima S; Nakamura K; Mitsuhashi T
    Br J Radiol; 1991 Mar; 64(759):272-5. PubMed ID: 1673633
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma.
    Shao YY; Huang CC; Liang PC; Lin ZZ
    Asia Pac J Clin Oncol; 2010 Jun; 6(2):80-8. PubMed ID: 20565419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current advances in molecular targeted therapy of primary hepatocellular carcinoma].
    Yu L; Dai Z; Zhou J; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):475-7. PubMed ID: 19567036
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy.
    Han KH; Park JY
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1023-5. PubMed ID: 20594213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.